Breaking News Headlines Today

News about Biotech

Stay current with all the latest and breaking news about Biotech, compare headlines and perspectives between news sources on stories happening today. In total, 95 stories have been published about Biotech which Ground News has aggregated in the past 3 months.

Covered Most By

DirectorsTalk Interviews

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Top Biotech News

Electric Vehicles · China

China signals it will pull plug on subsidies for EVs with five-year plan exclusion

50% Center coverage: 16 sources

China has sent a clear signal that it is willing to pull the plug on subsidies for its electric vehicle industry after years of big-ticket government support fuelled a boom that has left the world's second-largest economy saddled with vast oversupply, prompting it to push into global car markets.See the Story

Mergers & Acquisitions · Dallas

Colossal Biosciences Buys Cloning Leader Viagen

75% Center coverage: 8 sources

See the Story

Health

Specific human gene can help the heart repair itself from heart attack or heart failure

60% Center coverage: 5 sources

See the Story

Colossal Biosciences Buys Cloning Leader Viagen

75% Center coverage: 8 sources

Mergers & Acquisitions · Dallas See the Story

Biotech’s biggest challenge isn’t scientific, but political – with James Roosevelt Jr

100% Center coverage: 1 sources

Biotech’s biggest challenge isn’t scientific, but political – with James Roosevelt Jr Mike.Hammerton Tue, 04/11/2025 - 15:00 Bookmark thisBiotech Read Article

Specific human gene can help the heart repair itself from heart attack or heart failure

60% Center coverage: 5 sources

Health See the Story

Why the Tide in Biotech May Finally Be Turning and What iShares Biotechnology ETF (IBB) Signals

100% Left coverage: 1 sources

Key PointsAcquired 77,000 shares, valued at $11.1 millionTransaction represents 8.7% of 13F reportable AUMPost-trade position: 77,000 shares valued at $11.1 millionIBB is now the fund’s 2nd-largest holding, accounting for 8.7% of AUMThese 10 stocks could mint the next wave of millionaires › @media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: Getty Images…Biotech · United States Read Article

Patents, Italy Lags Behind on Digital, Biotech and Ai - Research and Institutions

100% Center coverage: 1 sources

And there is an increasingly marked escape of large enterprises (ANSA)Biotech · Italy Read Article

Money managers scrutinize tech valuations, eye options abroad

100% Center coverage: 1 sources

It’s still unclear if U.S. AI companies are overvalued, but some investors are looking for opportunities beyond Silicon ValleyBiotech · California See the Story

Best Biotech Stocks To Follow Today - October 31st

100% Center coverage: 1 sources

Danaher, Moderna, Vertex Pharmaceuticals, argenex, Recursion Pharmaceuticals, United Therapeutics, and Abivax are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies that research, develop, and commercialize medicines, diagnStock Markets Read Article

Opthea Limited (OPT) Stock Analysis: Navigating A -70.67% Potential Downside In Biotech

For investors keen on the biotechnology sector, Opthea Limited (NASDAQ: OPT), a clinical-stage biopharmaceutical company headquartered in Melbourne, Australia, may present a captivating yet complex opportunity. With a market capitalization of $583.1 million, Opthea focuses on developing therapies targeting vascular endothelial growth factors (VEGF) for eye diseases, including wet age-related macular degeneration (Wet AMD) and diabetic macular ed…Biotech · Melbourne Read Article

NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth - KKR (NYSE:KKR), Nanobiotix (NASDAQ:NBTX)

100% Center coverage: 1 sources

$71 million in funding would extend Nanobiotix cash visibility into early 2028 Transaction enables Nanobiotix development beyond key milestones in head and neck cancer and lung cancer Financing establishes financial foundation toward self-sustainability and the advancement of next wave nanotherapeutic platforms for long-term growth HealthCare Royalty (HCRx) will receive a capped portion of milestones and royalties on sales of JNJ-1900 (NBTXR3) p…KKR · Paris See the Story

Biotech might be tiny but the dealmaking is mighty

100% Center coverage: 1 sources

Also this week: A look at Kura and Syndax as they vie for market share among AML patients, and why Intellia faces an existential crisis.Biotech · Boston Read Article

News about Biotech

News about Biotech

Covered Most By

Local News Publishers

Top Biotech News

China signals it will pull plug on subsidies for EVs with five-year plan exclusion

Colossal Biosciences Buys Cloning Leader Viagen

Specific human gene can help the heart repair itself from heart attack or heart failure

Colossal Biosciences Buys Cloning Leader Viagen

Biotech’s biggest challenge isn’t scientific, but political – with James Roosevelt Jr

Specific human gene can help the heart repair itself from heart attack or heart failure

Why the Tide in Biotech May Finally Be Turning and What iShares Biotechnology ETF (IBB) Signals

Patents, Italy Lags Behind on Digital, Biotech and Ai - Research and Institutions

Money managers scrutinize tech valuations, eye options abroad

Best Biotech Stocks To Follow Today - October 31st

Opthea Limited (OPT) Stock Analysis: Navigating A -70.67% Potential Downside In Biotech

NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth - KKR (NYSE:KKR), Nanobiotix (NASDAQ:NBTX)

Biotech might be tiny but the dealmaking is mighty

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to Biotech

Colossal Biosciences Buys Cloning Leader Viagen

Biotech’s biggest challenge isn’t scientific, but political – with James Roosevelt Jr

Specific human gene can help the heart repair itself from heart attack or heart failure

Why the Tide in Biotech May Finally Be Turning and What iShares Biotechnology ETF (IBB) Signals

Patents, Italy Lags Behind on Digital, Biotech and Ai - Research and Institutions

Money managers scrutinize tech valuations, eye options abroad

Best Biotech Stocks To Follow Today - October 31st

Opthea Limited (OPT) Stock Analysis: Navigating A -70.67% Potential Downside In Biotech

NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth - KKR (NYSE:KKR), Nanobiotix (NASDAQ:NBTX)

Biotech might be tiny but the dealmaking is mighty